CRISPR Therapeutics Shatters LDL Targets, Boosts Lipid‑Lowering Gene‑Editing Promise
CRISPR Therapeutics shows early‑stage gene‑editing therapy cuts LDL‑C dramatically, promising a single‑shot lipid‑lowering breakthrough that could reshape cardiovascular treatment.
3 minutes to read
